Reuters logo
BRIEF-Avexis Q4 loss per share $0.92
March 16, 2017 / 8:28 PM / 9 months ago

BRIEF-Avexis Q4 loss per share $0.92

March 17 (Reuters) - Avexis Inc

* Avexis reports topline results from phase 1 trial of avxs-101 in SMA type 1 and fourth quarter and full year 2016 financial and operating results

* Q4 loss per share $0.92

* Q4 earnings per share view $-0.80 -- Thomson Reuters I/B/E/S

* Avexis Inc says no new treatment-related safety or tolerability findings in phase 1 trial of avxs-101

* Avexis Inc says as of January 20, 2017, avxs-101 appeared to have a favorable safety profile and to be generally well tolerated Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below